Literature DB >> 9209264

Identification of cell types producing RANTES, MIP-1 alpha and MIP-1 beta in rat experimental autoimmune encephalomyelitis by in situ hybridization.

R Miyagishi1, S Kikuchi, C Takayama, Y Inoue, K Tashiro.   

Abstract

The chemokines RANTES, macrophage inflammatory protein (MIP)-1 alpha and MIP-1 beta are members of the beta-family of chemokines and potent chemoattractants for lymphocytes and monocytes. To investigate the factors which regulate lymphocyte traffic in experimental autoimmune encephalomyelitis (EAE), we studied, by in situ hybridization analysis, the kinetics of mRNA expression and the potent cellular sources of RANTES, MIP-1 alpha and MIP-1 beta in the central nervous system (CNS) during the course of EAE. RANTES-positive cells appeared in the subarachnoid space and infiltrated the subpial region at around day 10, increased to a peak at days 12-13 and then decreased following the resolution of the acute phase of EAE, though elevated RANTES message expressions still remained on chronic subclinical stage. Most of RANTES positive cells were identified as T-lymphocytes located mainly around blood vessels, by combined studies of in situ hybridization and immunohistochemistry. The remainder of the RANTES-positive cells were astrocytes and macrophages/microglia. MIP-1 alpha and MIP-1 beta mRNA-positive cells appeared around day 10, increased further on days 12-13 and then gradually decreased. Most of the MIP-1 alpha- and MIP-1 beta-positive mononuclear cells were located around blood vessels. The kinetics of RANTES, MIP-1 alpha and MIP-1 beta expression paralleled those of the recruitment of infiltrating inflammatory cells and disease severity. Our observations support the possibility that chemokine production by T-cells, macrophages and astrocytes lead to the infiltration of inflammatory cells into the CNS parenchyma during the acute phase of EAE.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9209264     DOI: 10.1016/s0165-5728(97)00040-4

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  27 in total

Review 1.  Chemokines and glial cells: a complex network in the central nervous system.

Authors:  Elena Ambrosini; Francesca Aloisi
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

Review 2.  Role of chemokines in the regulation of Th1/Th2 and autoimmune encephalomyelitis.

Authors:  K J Kennedy; W J Karpus
Journal:  J Clin Immunol       Date:  1999-09       Impact factor: 8.317

3.  Elevated interferon gamma expression in the central nervous system of tumour necrosis factor receptor 1-deficient mice with experimental autoimmune encephalomyelitis.

Authors:  Rachel D Wheeler; Simone P Zehntner; Lisa M Kelly; Lyne Bourbonnière; Trevor Owens
Journal:  Immunology       Date:  2006-06-16       Impact factor: 7.397

Review 4.  CCR5 blockade for neuroinflammatory diseases--beyond control of HIV.

Authors:  Guillaume Martin-Blondel; David Brassat; Jan Bauer; Hans Lassmann; Roland S Liblau
Journal:  Nat Rev Neurol       Date:  2016-01-18       Impact factor: 42.937

5.  The chemokine receptor antagonist, TAK-779, decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system, without affecting T cell function.

Authors:  Jia Ni; Yi-Na Zhu; Xiang-Gen Zhong; Yu Ding; Li-Fei Hou; Xian-Kun Tong; Wei Tang; Shiro Ono; Yi-Fu Yang; Jian-Ping Zuo
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

6.  Deletion of cationic amino acid transporter 2 exacerbates dextran sulfate sodium colitis and leads to an IL-17-predominant T cell response.

Authors:  Kshipra Singh; Lori A Coburn; Daniel P Barry; Mohammad Asim; Brooks P Scull; Margaret M Allaman; Nuruddeen D Lewis; M Kay Washington; Michael J Rosen; Christopher S Williams; Rupesh Chaturvedi; Keith T Wilson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-05-23       Impact factor: 4.052

7.  The novel role of IL-7 ligation to IL-7 receptor in myeloid cells of rheumatoid arthritis and collagen-induced arthritis.

Authors:  Zhenlong Chen; Seung-jae Kim; Nathan D Chamberlain; Sarah R Pickens; Michael V Volin; Suncica Volkov; Shiva Arami; John W Christman; Bellur S Prabhakar; William Swedler; Anjali Mehta; Nadera Sweiss; Shiva Shahrara
Journal:  J Immunol       Date:  2013-04-19       Impact factor: 5.422

8.  Activation of group III metabotropic glutamate receptors inhibits the production of RANTES in glial cell cultures.

Authors:  Gilbert Besong; Giuseppe Battaglia; Mara D'Onofrio; Roberto Di Marco; Richard Teke Ngomba; Marianna Storto; Marzia Castiglione; Katia Mangano; Carla L Busceti; Ferdinando R Nicoletti; Kevin Bacon; Michael Tusche; Ornella Valenti; Peter Jeffrey Conn; Valeria Bruno; Ferdinando Nicoletti
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

9.  Global profiling of double stranded RNA- and IFN-gamma-induced genes in rat pancreatic beta cells.

Authors:  J Rasschaert; D Liu; B Kutlu; A K Cardozo; M Kruhøffer; T F ØRntoft; D L Eizirik
Journal:  Diabetologia       Date:  2003-11-05       Impact factor: 10.122

10.  CCR2-64I and CCR5Delta32 Polymorphisms in Korean Patients with Myasthenia Gravis.

Authors:  Hyun Sook Kim; Dae-Seong Kim; Eun Young Lee; Il-Nam Sunwoo; Young-Chul Choi
Journal:  J Clin Neurol       Date:  2007-09-20       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.